Suppr超能文献

相似文献

1
Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
Arterioscler Thromb Vasc Biol. 2010 May;30(5):909-14. doi: 10.1161/ATVBAHA.110.204099. Epub 2010 Mar 11.
2
Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1894-903. doi: 10.1152/ajpheart.00289.2015. Epub 2015 Oct 9.
3
Soluble epoxide hydrolase inhibition modulates vascular remodeling.
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H795-806. doi: 10.1152/ajpheart.00543.2009. Epub 2009 Dec 24.
4
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H2128-34. doi: 10.1152/ajpheart.00428.2008. Epub 2008 Oct 3.
5
Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
J Pharmacol Exp Ther. 2008 Dec;327(3):707-15. doi: 10.1124/jpet.108.142398. Epub 2008 Sep 24.
6
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Mol Neurobiol. 2015 Aug;52(1):187-95. doi: 10.1007/s12035-014-8833-3. Epub 2014 Aug 17.
7
Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
J Mol Cell Cardiol. 2016 Sep;98:128-37. doi: 10.1016/j.yjmcc.2016.08.001. Epub 2016 Aug 3.
10
Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
J Pharmacol Exp Ther. 2006 Sep;318(3):1307-14. doi: 10.1124/jpet.106.103556. Epub 2006 Jun 13.

引用本文的文献

2
Mix-and-Read Nanobody-Based Sandwich Homogeneous Split-Luciferase Assay for the Rapid Detection of Human Soluble Epoxide Hydrolase.
Anal Chem. 2023 Apr 11;95(14):6038-6045. doi: 10.1021/acs.analchem.3c00079. Epub 2023 Mar 27.
3
The epoxy fatty acid pathway enhances cAMP in mammalian cells through multiple mechanisms.
Prostaglandins Other Lipid Mediat. 2022 Oct;162:106662. doi: 10.1016/j.prostaglandins.2022.106662. Epub 2022 Jun 30.
5
sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae.
J Clin Invest. 2021 Nov 15;131(22). doi: 10.1172/JCI129679.
7
A novel interaction between soluble epoxide hydrolase and the AT1 receptor in retinal microvascular damage.
Prostaglandins Other Lipid Mediat. 2020 Jun;148:106449. doi: 10.1016/j.prostaglandins.2020.106449. Epub 2020 Apr 30.
8
Lipid mediators in immune regulation and resolution.
Br J Pharmacol. 2019 Apr;176(8):1009-1023. doi: 10.1111/bph.14587. Epub 2019 Mar 1.
9
3D Imaging and Quantitative Analysis of Vascular Networks: A Comparison of Ultramicroscopy and Micro-Computed Tomography.
Theranostics. 2018 Mar 7;8(8):2117-2133. doi: 10.7150/thno.22610. eCollection 2018.

本文引用的文献

1
Soluble epoxide hydrolase inhibition modulates vascular remodeling.
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H795-806. doi: 10.1152/ajpheart.00543.2009. Epub 2009 Dec 24.
2
MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries.
J Exp Med. 2008 Dec 22;205(13):3159-71. doi: 10.1084/jem.20081298. Epub 2008 Dec 8.
3
Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice.
Arterioscler Thromb Vasc Biol. 2009 Jan;29(1):54-60. doi: 10.1161/ATVBAHA.108.171298. Epub 2008 Oct 16.
4
Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model.
J Cardiovasc Pharmacol. 2008 Oct;52(4):314-23. doi: 10.1097/FJC.0b013e318185fa3c.
5
Role of the renin-angiotensin system in vascular inflammation.
Trends Pharmacol Sci. 2008 Jul;29(7):367-74. doi: 10.1016/j.tips.2008.05.003. Epub 2008 Jun 23.
6
Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein.
Growth Factors. 2008 Apr;26(2):80-91. doi: 10.1080/08977190802025602.
7
Circulating smooth muscle progenitor cells: novel players in plaque stability.
Cardiovasc Res. 2008 Feb 1;77(3):445-7. doi: 10.1093/cvr/cvm088. Epub 2007 Dec 4.
8
Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways.
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H142-51. doi: 10.1152/ajpheart.00783.2006. Epub 2007 Feb 23.
9
Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.
Trends Pharmacol Sci. 2007 Jan;28(1):32-8. doi: 10.1016/j.tips.2006.11.002. Epub 2006 Dec 5.
10
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
Circ Res. 2006 Aug 18;99(4):442-50. doi: 10.1161/01.RES.0000237390.92932.37. Epub 2006 Jul 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验